PURMX Therapeutics (headquartered in Hiroshima, Japan; Hidetoshi Tahara, President & CEO; hereinafter referred to as "the Company") has received the "Special Award for Academic Startups" at the "Award for Academic Startups" hosted by the National Science and Technology Agency (JST) for the fiscal year 2022.
(headquartered in Hiroshima City, Japan; President: Hidetoshi Tahara; hereinafter referred to as "the Company") has received the "Special Award for Academic Startups" at the "Award for Academic Startups" organized by the Japan Science and Technology Agency (JST) for fiscal year 2022.
Press_2022_9_8_Eng
.pdf
Download PDF • 453KB